🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment

Recruitingn/aAges 18 Years - anyAllBial - Portela C S.A.
NCT07145190 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of the study is to generate real-world evidence data for the on-demand treatment with SL-APO, focusing on understanding its usage and titration practices including individual dose determination after dose-adjustment to ultimately understand their influence in patient satisfaction, treatment persistence, and the balance between effectiveness and safety. The data may help optimize titration approaches to better meet the patient's needs.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * The patient is ≥ 18 years of age. * The patient has a clinical diagnosis of idiopathic Parkinson's disease. * The patient will initiate SL-APO for the treatment of OFF episodes according to the SmPC. * The patient is not currently on titration or maintenance dose for SL-APO. * The patient has provided written informed consent to participate in this study. Exclusion Criteria: * The patient is participating in a clinical trial with an investigational drug. * The patient has presented with dementia or evidence of cognitive decline as determined by the investigator. * The patient has a history of psychotic disorder. * The patient presents any other contraindication according to the SL-APO SmPC.
💊

What it tests

  • SL-APO
📍

Where

12 sites
Charité - Universitätsmedizin Berlin - Sektion für Bewegungsstörungen und Neuromodulation
Berlin, Germany
Alexianer St. Joseph Berlin-Weißensee GmbH
Berlin, Germany
Praxis für Neurologie
Berlin, Germany
Katholisches Klinikum Bochum gGmbH, Universitätsklinikum St.Josef-Hospital, Klinik für Neurologie
Bochum, Germany
UNIVERSITÄTSKLINIKUM FREIBURG - Neurozentrum Klinik für Neurologie und Neurophysiologie im Neurozentrum
Freiburg im Breisgau, Germany
Praxis für Neurologie und Psychiatrie
Fulda, Germany
Klinik am Tharandter Wald
Hetzdorf, Germany
Klinik für Neurologie und Neurologische Frührehabilitation
Osnabrück, Germany

…and 4 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy